FDA Drug Application (200429) for NAPROXEN by AUROBINDO PHARMA USA

Back to FDA Applications sponsored by AUROBINDO PHARMA USA

Application Number200429
Product Number001
FormTABLET;ORAL
Dosage250MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameNAPROXEN
Active IngredientNAPROXEN

Active IngredientCount
List of drugs with Active Ingredient NAPROXEN8


Back to FDA Applications sponsored by AUROBINDO PHARMA USA